✦ LIBER ✦

Clinical, Immunological and Genetic Spectrum Of Novel BTK Gene Mutations In X-Linked Agammaglobulinemia Patients and Female Carriers

✍ Scribed by Pyle, Regan; Hagan, John B.; Martinez, Amanda; Joshi, Avni Y.; Boyce, Thomas; Volcheck, Gerald W.; Yilmaz-Demirdag, Yesim; Bahna, Sami L.; Abraham, Roshini S.

Book ID: 122299984
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 44 KB
Volume: 133
Category: Article
ISSN: 1097-6825
DOI: 10.1016/j.jaci.2013.12.051

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BTK: 22 novel and 25 recurrent mutations

BTK: 22 novel and 25 recurrent mutations in European patients with X-linked agammaglobulinemia

✍ Maurilia Fiorini; Roberta Franceschini; Annarosa Soresina; Richard-Fabian Schuma 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Communicated by

Identification of mutations of Bruton's

Identification of mutations of Bruton's tyrosine kinase gene (BTK) in Brazilian patients with X-linked agammaglobulinemia

✍ Sergio Massayuki Tani; Yue Wang; Hirokazu Kanegane; Takeshi Futatani; Jorge Pint 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

Mutations in the Bruton tyrosine kinase (BTK) gene are responsible for X-linked agammaglobulinemia (XLA), which is characterized by recurrent bacterial infections, profound hypogammaglobulinemia, and decreased numbers of mature B cells in the peripheral blood. We evaluated 17 male Brazilian patients

Mutations of the human BTK gene coding f

Mutations of the human BTK gene coding for bruton tyrosine kinase in X-linked agammaglobulinemia

✍ Mauno Vihinen; Sau-Ping Kwan; Tracy Lester; Hans D. Ochs; Igor Resnick; Jouni Vä 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB 👁 2 views

## X-linked agammaglobulinemia (XLA) is an immunodeficiency caused by mutations in the gene coding for Bruton agammaglobulinemia tyrosine kinase (BTK). A database (BTKbase ) of BTK mutations lists 544 mutation entries from 471 unrelated families showing 341 unique molecular events. In addition to

BTK mutations in patients with X-linked

BTK mutations in patients with X-linked agammaglobulinemia: Lack of correlation between presence of peripheral B lymphocytes and specific mutations

✍ Luan Tao; Mark Boyd; Greg Gonye; Barbara Malone; Jerrold Schwaber 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 2 views

Clinical features and mutation analysis

Clinical features and mutation analysis of X-linked agammaglobulinemia in 20 Chinese patients

✍ Xian Qin, Li-Ping Jiang, Xue-Mei Tang, Mo Wang, En-Mei Liu… 📂 Article 📅 2013 🏛 SP Children’s Hospital, Zhejiang University School 🌐 English ⚖ 586 KB

Identification of the bruton tyrosine ki

Identification of the bruton tyrosine kinase (BTK) gene mutations in 20 Australian families with X-linked agammaglobulinemia (XLA)

✍ Marija Velickovic; Madhuri L. Prasad; Susan A. Weston; Elizabeth M. Benson 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 33 KB

X-linked agammaglobulinemia (XLA) is an immunodeficiency caused by mutations in the Bruton tyrosine kinase (BTK) gene. Twenty Australian patients with an XLA phenotype, from 15 unrelated families, were found to have 14 mutations. Five of the mutations were previously described c.83G>A (p.R28H), c.86